IP Library Granted Patent US 8,158,430
Granted Patent B1
US 8,158,430 · App. 12/221,816 · Granted Apr 17, 2012

Systems and methods of fluidic sample processing

Assignee: Theranos, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,158,430
App. No.
12/221,816
Granted
Apr 17, 2012
Kind
B1
Abstract

The present invention provides fluidic devices and systems that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.

Claims (17)

1. A method of calculating an apparent dilution ratio utilized in diluting a blood sample for running a blood test, comprising:

a) providing a plasma sample derived from a diluted blood sample;

b) measuring conductivity of the plasma sample; and

c) comparing the measured conductivity to a set of predetermined values showing relationship of conductivity values and dilution ratios that are employed to dilute a blood sample, thereby calculating the apparent dilution ratio utilized in diluting the blood sample.

2. The method of claim 1 , wherein the blood sample is diluted prior to running the blood test.

3. The method of claim 1 , wherein the plasma sample derived from a diluted blood sample is substantially free of red blood cells.

4. The method of claim 1 , wherein conductivity of the plasma sample is inversely proportional to the apparent dilution ratio.

5. The method of claim 1 , wherein the measuring of the conductivity of the plasma sample is performed using at least two electrodes spaced at different locations.

6. The method of claim 5 , wherein the electrodes are formed of stainless steel.

7. The method of claim 5 , wherein the electrodes are spaced apart by 5 mm to 20 mm.

8. The method of claim 1 , wherein an AC voltage is applied to the plasma sample.

9. The method of claim 8 , wherein a relationship between a current induced by the AC voltage applied and the conductivity of the plasma sample is determined.

10. The method of claim 9 , wherein the measured conductivity is amplified, reshaped, buffered, and/or sent to a microprocessor that outputs a DC voltage correlated to the measured conductivity.

11. The method of claim 1 , wherein the blood sample has a volume from about 1 uL to about 500 uL.

12. The method of claim 1 , wherein the predetermined values form a substantially linear calibration curve.

13. The method of claim 1 , wherein the temperature of the plasma sample is fixed.

14. The method of claim 1 , wherein the conductivity is measured with a calibration unit contained in a device that also collects the blood sample.

Assignments (5)
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2018
From: THERANOS, INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 045101/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: THERANOS INC.
To: THERANOS IP COMPANY, LLC
Reel/Frame 044838/0909 →
SECURITY INTEREST Recorded Dec 12, 2017
From: THERANOS IP COMPANY, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 044839/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2008
From: ROY, SHAUNAK; TAKAHASHI, MELISSA; GIBBONS, IAN; KU, EDMOND; DANG, THANH; BURD, TAMMY; HOLMES, ELIZABETH A.; VOLLMER, ADAM
To: THERANOS, INC.
Reel/Frame 021812/0499 →
Continuity (1)
Provisional Application 60954301 · Aug 6, 2007